Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-
Brief Summary: Randomized. double blind, placebo controlled, parallel arms dose finding study with a 4 weeks treatment period